Proliferating cell nuclear antigen (PCNA) overexpression in hepatocellular carcinoma predicts poor prognosis as determined by bioinformatic analysis

Dan-Dan Li; Jia-Wei Zhang; Rui Zhang; Jie-Hong Xie; Kuo Zhang; Gui-Gao Lin; Yan-Xi Han; Rong-Xue Peng; Dong-Sheng Han; Jie Wang; Jing Yang; Jin-Ming Li

doi:10.1097/CM9.0000000000001192

Proliferating cell nuclear antigen (PCNA) overexpression in hepatocellular carcinoma predicts poor prognosis as determined by bioinformatic analysis

Chin Med J (Engl). 2020 Nov 3;134(7):848-850. doi: 10.1097/CM9.0000000000001192.

Authors

Dan-Dan Li^{1

2

3}, Jia-Wei Zhang^{1

2

3}, Rui Zhang^{1

2

3}, Jie-Hong Xie^{1

2

3}, Kuo Zhang^{1

2

3}, Gui-Gao Lin^{1

2

3}, Yan-Xi Han^{1

2

3}, Rong-Xue Peng^{1

2

3}, Dong-Sheng Han^{1

2

3}, Jie Wang^{1

2

3}, Jing Yang^{1

2

3}, Jin-Ming Li^{1

2

3}

Affiliations

¹ National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100005, China.
² Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
³ Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing 100005, China.

No abstract available

MeSH terms

Carcinoma, Hepatocellular* / genetics
Computational Biology
Humans
Liver Neoplasms* / genetics
Prognosis
Proliferating Cell Nuclear Antigen

Substances

Proliferating Cell Nuclear Antigen